Phibro Animal Health (PAHC) EBITDA Margin Growth (3y) (2015 - 2026)
Phibro Animal Health (PAHC) EBITDA Margin Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 1,129.00 |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | 2.00 |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | 59.00 |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | -1,031.00 |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | -925.00 |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | -46.00 |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 6,666.00 |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | Phibro Animal Health | 1.44 Bn | 1.36 Bn | 125.68 Mn | 409.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 409.00 |
| Dec 31, 2025 | 698.00 |
| Sep 30, 2025 | 820.00 |
| Jun 30, 2025 | -6.00 |
| Mar 31, 2025 | 163.00 |
| Dec 31, 2024 | -132.00 |
| Sep 30, 2024 | -1.00 |
| Jun 30, 2024 | -196.00 |
| Mar 31, 2024 | -194.00 |
| Dec 31, 2023 | -337.00 |
| Sep 30, 2023 | -835.00 |
| Jun 30, 2023 | -43.00 |
| Mar 31, 2023 | -256.00 |
| Dec 31, 2022 | -269.00 |
| Sep 30, 2022 | 54.00 |
| Jun 30, 2022 | 303.00 |
| Mar 31, 2022 | -296.00 |
| Dec 31, 2021 | -220.00 |
| Sep 30, 2021 | -461.00 |
| Jun 30, 2021 | -363.00 |